The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical ...

A 55-year-old man’s swollen toes and fingers turned out to have a much stranger explanation than expected. In a recent case ...

The latest details of Indonesian Vice President Gibran Rakabuming Raka's assets show a Rp1.9 billion increase.

The Corruption Eradication Commission (KPK) has released the Wealth Report of State Officials (LHKPN) for President Prabowo ...

In a complete response letter, the FDA indicates the drug trial is not an adequate, well-controlled clinical investigation, ...

The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.